Cancer Treatment Using TTFields and Interferon Gamma Compositions

This document is a patent application (US20260083819A1) published by the USPTO, disclosing novel methods for cancer treatment. The invention combines Tumor Treating Fields (TTFields) with interferon gamma compositions to reduce cancer cell viability, treat cancer, and decrease tumor volume. The application was filed on September 18, 2025, and published on March 26, 2026.

As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it signals potential future developments and intellectual property in cancer therapeutics. Companies involved in oncology drug development or medical device manufacturing, particularly those working with TTFields or interferon gamma, should be aware of this filing for competitive intelligence and potential licensing opportunities.